Skip to content
Governance Register

← US public companies

Schor Chen

SEC-identified person · CIK 1340875 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Restorbio, Inc. TORC Director · See Remarks filed 2018–2026
Karyopharm Therapeutics Inc. KPTI Director filed 2020–2026
Brainstorm Cell Therapeutics INC. BCLI] Director filed 2011–2018
Synta Pharmaceuticals Corp SNTA Director · President and CEO filed 2014–2016
Epix Pharmaceuticals, Inc. EPIX Chief Business Officer filed 2006–2009

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.